The Laboratory Virology and Serology Reporting Scheme, 1991 to 2000

The Laboratory Virology and Serology (LabVISE) Reporting Scheme is a passive surveillance scheme based on voluntary reports of infectious agents contributed by virology and serology laboratories around Australia. This article reports on the LabVISE data collected between 1991 and 2000 and was published in Communicable Diseases Intelligence Vol 26 No 3, September 2002. This article can be viewed in 15 HTML documents and is also available in PDF format.

Page last updated: 03 October 2002

A print friendly PDF version is available from this Communicable Diseases Intelligence issue's table of contents.




Table of contents



Top of page

Abbreviations

CMV - Cytomegalovirus
CNS - Central nervous system
DAD - Disseminated adenovirus disease
DNA - Deoxyribonucleic acid
EBV - Epstein-Barr virus
HEV - Hepatitis E virus
HPIV - Human parainfluenza viruses
HPV - Human papillomaviruses
HSV-2 - Herpes simplex virus type 2
LabDOSS - Laboratory Database of Organisms from Sterile Sites
LabVISE - Laboratory Virology and Serology Reporting Scheme
MMR - Measles-mumps-rubella vaccine
NLV - Norwalk-like virus
NNDSS - National Notifiable Diseases Surveillance System
PHLN - Public Health Laboratory Network
RRV - Ross River virus
RSV - Respiratory syncytial virus
USA - United States of America
WHO - World Health Organization


This article was published in Communicable Diseases Intelligence Volume 26, No 3, September 2002

In this section

CDI Search

Search Communicable Diseases Intelligence

Communicable Diseases Intelligence subscriptions

Sign-up to email updates: Subscribe Now

Communicable Diseases Surveillance

This issue - Vol 26, No 3, September 2002

Communicable Diseases Intelligence